Sanofi India has reported results for first quarter ended March 31, 2015
The company has posted a rise of 24.76% in its net profit at Rs 64.5 crore for the quarter ended March 31, 2015 as compared to Rs 51.7 crore for the same quarter in the previous year. Total income of the company has increased by 8.98% at Rs 508.3 crore for quarter under review as compared to Rs 466.4 crore for the quarter ended March 31, 2014.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1505.20 |
Dr. Reddys Lab | 5922.45 |
Cipla | 1339.45 |
Zydus Lifesciences | 983.05 |
Lupin | 1609.85 |
View more.. |